Overdose the addiction--A new strategy to ablate cancer cells.
Department of Experimental Radiation Oncology, Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA. leili@mdanderson.org.
Lei
L
Li
D000818:Animals; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D003512:Cyclohexanones / Q000494:pharmacology*; D005260:Female; D057809:HEK293 Cells; D006367:HeLa Cells; D006801:Humans; D015151:Immunoblotting; D061986:MCF-7 Cells; D008819:Mice, Nude; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control*; D056920:Nuclear Receptor Coactivator 1 / Q000235:genetics / Q000378:metabolism*; D051958:Nuclear Receptor Coactivator 2 / Q000235:genetics / Q000378:metabolism*; D056921:Nuclear Receptor Coactivator 3 / Q000235:genetics / Q000378:metabolism*; D011725:Pyridines / Q000494:pharmacology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D047368:Tumor Burden / Q000187:drug effects; D023041:Xenograft Model Antitumor Assays
C000602902:4-ethyl-2,6-bispyridin-3-ylmethylenecyclohexanone; D003512:Cyclohexanones; D051958:Nuclear Receptor Coactivator 2; D011725:Pyridines; D056920:Nuclear Receptor Coactivator 1; D056921:Nuclear Receptor Coactivator 3